
IQVIA Hlds (IQV) Stock Forecast & Price Target
IQVIA Hlds (IQV) Analyst Ratings
Bulls say
IQVIA Holdings demonstrated a positive financial outlook, as evidenced by year-over-year growth in key segments such as FSP, RWE, and CSMS, particularly noted in Q3. The company is experiencing momentum in its commercial operations, supported by improved client decision timelines, a robust pipeline fueled by recent drug launches, and a significant increase in request-for-proposal (RFP) flow. Additionally, IQVIA's confidence in achieving a 4%+ growth rate in its Research & Development Services (R&DS) segment, along with improvements in pricing dynamics and a stronger win rate, further underlines its favorable performance trajectory.
Bears say
The financial outlook for IQVIA Holdings appears to be negative due to several core issues. Year-over-year constant currency growth has declined from 6.8% to 3.8%, indicating potential challenges in maintaining revenue momentum, particularly with a projected slow down in real-world evidence due to tough comparisons. Additionally, rising interest rates may exert further downward pressure on earnings, compounded by a decreased hiring rate and an increasing reliance on passthroughs that are negatively impacting margins.
This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.
IQVIA Hlds (IQV) Analyst Forecast & Price Prediction
Start investing in IQVIA Hlds (IQV)
Order type
Buy in
Order amount
Est. shares
0 shares